Best StreetInsider.com tickers, 10/1/2022
Enter Wall Street with Street Insider Premium. Claim your 1-week free trial here.
Pursuant to Articles L-223-8 II of the Commercial Code and 223-16 of the AMF General Regulations.
SOPHIA ANTIPOLIS, France – (BUSINESS WIRE) – Regulatory news:
Médiane Technologies (Paris: ALMDT):
Total number of shares
Number of actual voting rights *
15 450 156
Theoretical number of voting rights *
Class E preferred shares are non-voting
(**) in application of article 223-11 of the AMF general regulations About Median Technologies:
Median Technologies provides innovative imaging solutions and services to advance healthcare for all. We leverage the power of phenomenal imagery to provide insight into new therapies and treatment strategies. Our unique solutions for the analysis and management of medical images in oncology trials and iBiopsy® for imaging phenotyping, along with our global team of experts, are advancing the development of new drugs and diagnostic tools to monitor disease and assess response to treatment. Median Technologies supports biopharmaceutical sponsors and healthcare professionals around the world to quickly and accurately deliver new treatments to patients in need. This is how we help create a healthier world.
Head of corporate communication and marketing
+33 6 10 93 58 88
Press – ALIZE RP
+33 6 64 18 99 59
Investors – ACTIFIN
+33 6 21 10 49 24
Source: Mid-range technologies
Serious news for serious traders! Try StreetInsider.com Premium for free!